Performance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in Cuba

Article

Abstract: As commercial human immunodeficiency virus type 1 drug resistance assays are expensive, they are not

Palabras claves:

Autores:

Abrahantes Y., Alemán-Campos Y., Álvarez A.A., Consuelo Beatriz Correa, Fonseca-Gómez C., Kourí-Cardellá V., Pérez L., Pérez-Avila J., Schrooten Y., Soto-Brito Y., Van Laethem K., Vandamme A.M., Vinken L.

Fuentes:

scopus